Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer : a systematic review
Citation
Chatterji , S , Krzoska , E , Thoroughgood , C W , Saganty , J , Liu , P , Elsberger , B , Abu Eid , R & Speirs , V 2023 , ' Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer : a systematic review ' , The Lancet Oncology , vol. 24 , no. 2 , pp. e74-e85 . https://doi.org/10.1016/S1470-2045(22)00633-7
Rights
© 2023. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/